Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,262Revenue (TTM) $M32,574Net Margin (%)0.3Altman Z-Score2.9
Enterprise Value $M13,316EPS (TTM) $0.1Operating Margin %1.7Piotroski F-Score5
P/E(ttm)74.4Beneish M-Score-2.5Pre-tax Margin (%)0.4Higher ROA y-yN
Price/Book9.710-y EBITDA Growth Rate %--Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.25-y EBITDA Growth Rate %17.2Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-11.2ROA % (ttm)0.8Higher Current Ratio y-yY
Dividend Yield %--PEG4.6ROE % (ttm)15.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M1,052ROIC % (ttm)6.6Gross Margin Increase y-yN

Gurus Latest Trades with RAD

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

RAD is held by these investors:



RAD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Donley Douglas ESVP 2016-06-15Sell34,106$7.77-23.42view
Montini TonyEVP 2015-07-09Sell353,194$8.38-29view
ANDERSON JOSEPH B JRDirector 2015-04-15Sell150,000$8.25-27.88view
Thompson Robert KEVP 2015-04-13Sell95,850$8.33-28.57view
SYMS MARCYDirector 2015-04-10Sell150,000$8.26-27.97view
Donley Douglas ESVP & CAO 2015-04-10Sell59,404$8.21-27.53view
Montini TonyEVP 2014-12-29Sell49,525$7.47-20.35view
Montini TonyEVP 2014-12-23Sell259,750$6.92-14.02view
STANDLEY JOHN TChairmain/CEO 2014-12-22Sell1,700,000$6.82-12.76view
STRASSLER MARC AEVP 2014-12-22Sell575,975$6.79-12.37view

Quarterly/Annual Reports about RAD:

News about RAD:

Articles On GuruFocus.com
David Einhorn Buys Buffett’s Monsanto, Retail, Apple in Q4 Feb 15 2017 
Walgreens, Rite Aid Reduce Price, Postpone Closing of Merger Jan 30 2017 
Dividend Aristocrats in Focus Part 38: Walgreens Boots Alliance Nov 10 2016 
Why I Am Now Interested in CVS Health Corporation Oct 13 2016 
Rite Aid Is a Solid Risk Arbitrage Trade Sep 27 2016 
Why Walgreens Is a Long-Term Buy Now Sep 09 2016 
David Einhorn Adds Calpine, Rite Aid, Amaya to Portfolio Aug 16 2016 
CVS and Walgreens: A Duopoly That's Hard to Ignore Jul 08 2016 
In Spite of Less Revenue Rite Aid Still Has Growth Potential Jun 21 2016 
Walgreens Boots Alliance: 40 Consecutive Years of Dividend Growth and Counting Jun 17 2016 

More From Other Websites
What's working: Health and housing plays Feb 21 2017
At Long Last Walgreens and Rite Aid May Soon Be One Company Feb 16 2017
Einhorn Takes Fred's Stake Amid Deal Review Feb 16 2017
3 Stocks to Buy for Under $10 With 25%-Plus Upside Feb 16 2017
David Einhorn Buys Buffett's Monsanto, Retail, Apple in Q4 Feb 15 2017
Rite Aid Expands Naloxone Dispensing Program in Six Additional States Feb 15 2017
Greenlight Capital Bets on General Motors, Rite Aid Feb 14 2017
Wall Street's M&A Chatter From February 10-12 Feb 13 2017
Buy Rite Aid Because It's Very Likely to Be Owned by Walgreens Soon Feb 10 2017
CVS Health Earnings Growth Tops, But Sales Miss Estimates Feb 09 2017
Nvidia, Twitter, Yum, CVS, Expedia Lead Investing Action Plan Feb 08 2017
Implied Volatility Surging for Rite Aid (RAD) Stock Options Feb 06 2017
Rite Aid, Pitney Bowes Welcomed to Wednesday’s 52-Week Low Club Feb 01 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)